C0299275||4-phenylcoumarin
C1254351||geopropolis
C0920472||drug discovery
C0243095||natural sources
C2603343||study
C1510686||ADME
C0010206||coumarin
C1254351||geopropolis
C1254351||Cinnamoyloxy-mammeisin
C1254351||Cinnamoyloxy-mammeisin
C0006137||Brazilian
C1499394||M. scutellaris
C1254351||geopropolis
C0282574||ACD/Percepta™
C0282574||MetaDrug™ software
C0012860||DNA damage
C3899376||PCR array
C1254351||Cinnamoyloxy-mammeisin
C0282574||parameters
C0282574||Lipinski's rule of five
C0442027||oral
C0032119||plasma protein binding
C1254351||Cinnamoyloxy-mammeisin
C0010762||cytochrome P450 family
C1254351||Cinnamoyloxy-mammeisin
C0178784||organs
C0040300||tissues
C0023884||liver
C0022646||kidney
C0152030||skin
C0235266||eye irritation
C3899376||PCR array
C1254351||Cinnamoyloxy-mammeisin
C0041904||upregulated
C0012860||DNA damage-related
C0017337||genes
C3714634||biological function
C0017337||genes
C1254351||Cinnamoyloxy-mammeisin
C0162638||apoptosis
C1510686||ADME
C1254351||Cinnamoyloxy-mammeisin
C0041904||upregulation
C0162638||apoptosis-related
C0017337||genes
C0087111||treatment
C0282574||parameters
C1709631||preclinical studies